Migraine Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are female and between 18 and 45 years of age
• People who have an established diagnosis of migraine
• People who had a straightforward delivery without lasting health complications for themselves
• People whose baby did not stay in a neonatal intensive care unit (NICU) for more than 3 nights
• People who are between 14 days and 9 months after giving birth, and are still breastfeeding, at the time of joining the trial
• People for whom a prescribing doctor has determined that a migraine medication called galcanezumab is appropriate to use after birth
• People who are planning to receive galcanezumab after giving birth

Who may not be able to join:

• People who have a medical reason they cannot breastfeed, including due to prior surgery or a condition affecting their baby
• People for whom galcanezumab is medically unsuitable, or for whom insurance does not cover it
• People who are currently using a group of migraine medications called gepants
• People who screen positive for moderately severe or severe depression (a score of 15 or above on a standard depression questionnaire called the PHQ-9)
• People who are currently pregnant or planning to become pregnant within the next 6 months
• People who have a severe breast infection (mastitis) at the time of joining
• People whose baby has significant health concerns noted in medical records, such as developmental issues, complications from birth, or the need for ongoing medications

Important: Always verify eligibility with the trial site directly before applying.